Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluation of AP-002 in Patients With Solid Tumors
- First Posted Date
- 2019-10-29
- Last Posted Date
- 2019-10-31
- Lead Sponsor
- Altum Pharmaceuticals INC
- Target Recruit Count
- 61
- Registration Number
- NCT04143789
- Locations
- 🇺🇸
Research Institution, Chicago, Illinois, United States
🇺🇸Research Site, Saint Louis, Missouri, United States
🇺🇸Investigational Site, Houston, Texas, United States
News
No news found